Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
ZimVie Inc. - Common Stock
(NQ:
ZIMV
)
18.99
UNCHANGED
Last Price
Updated: 4:00 PM EDT, Oct 17, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about ZimVie Inc. - Common Stock
< Previous
1
2
3
4
5
6
Next >
ZimVie to Report Third Quarter 2023 Financial Results on November 1, 2023
October 11, 2023
From
ZimVie Inc.
Via
GlobeNewswire
ZimVie Announces the Recent Launch of Biotivity™ A/C Plus Membrane
October 10, 2023
New offering broadens ZimVie’s dental portfolio into the expanding growth factor biomaterials market
From
ZimVie Inc.
Via
GlobeNewswire
ZimVie Announces FDA Approval to Launch Mobi-C® Hybrid Study
September 26, 2023
Decision clears the way for enrollment of U.S. patients in a groundbreaking clinical study of cervical arthroplasty adjacent to fusion
From
ZimVie Inc.
Via
GlobeNewswire
Barclays Maintains Underweight Rating for ZimVie: Here's What You Need To Know
↗
August 08, 2023
Via
Benzinga
ZimVie (ZIMV) Q2 2023 Earnings Call Transcript
↗
August 02, 2023
ZIMV earnings call for the period ending June 30, 2023.
Via
The Motley Fool
ZimVie Expands Development Cooperation Agreement with Brainlab AG to Include Co-Marketing
August 17, 2023
From
ZimVie Inc.
Via
GlobeNewswire
ZimVie Announces FDA Approval for New Mobi-C® Implant
August 10, 2023
Smaller height implants in all Mobi-C footprints to address patient anatomy
From
ZimVie Inc.
Via
GlobeNewswire
ZimVie Reports Second Quarter 2023 Financial Results and Provides Update to Annual Guidance
August 02, 2023
From
ZimVie Inc.
Via
GlobeNewswire
ZimVie's Earnings Outlook
↗
August 01, 2023
Via
Benzinga
ZimVie's Return On Capital Employed Insights
↗
May 12, 2023
Via
Benzinga
ZimVie (ZIMV) Q1 2023 Earnings Call Transcript
↗
May 04, 2023
ZIMV earnings call for the period ending March 31, 2023.
Via
The Motley Fool
ZimVie: Q1 Earnings Insights
↗
May 03, 2023
Via
Benzinga
Earnings Scheduled For August 2, 2023
↗
August 02, 2023
Companies Reporting Before The Bell • Vanguard Extended Duration Treasury ETF (NYSE:EDV) is estimated to report quarterly earnings at $0.37 per share on revenue of $784.53 million.
Via
Benzinga
Why Acumen Pharmaceuticals Shares Are Trading Higher By Over 60%? Here Are Other Stocks Moving In Monday's Mid-Day Session
↗
July 17, 2023
Gainers ProMIS Neurosciences, Inc. (NASDAQ: PMN) shares jumped 126.6% to $6.37. ProMIS showcased preclinical data at the Alzheimer's Association International Conference 2023 on computationally-derived...
Via
Benzinga
ZimVie to Report Second Quarter 2023 Financial Results on August 2, 2023
July 12, 2023
From
ZimVie Inc.
Via
GlobeNewswire
ZimVie to Present at the Stifel 2023 Jaws & Paws Conference
May 22, 2023
From
ZimVie Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Thursday's Intraday Session
↗
May 04, 2023
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
↗
May 04, 2023
Via
Benzinga
ZimVie Reports First Quarter 2023 Financial Results and Provides Update to Annual Guidance
May 03, 2023
From
ZimVie Inc.
Via
GlobeNewswire
ZimVie Opens State-of-the-Art Dental Science Educational and Training Institute in Palm Beach Gardens, Florida
April 27, 2023
Modernized 11,000 sq. ft. facility equipped for hands-on dental education and training underscores company’s commitment to lead the industry in advancing professional development of dental...
From
ZimVie Inc.
Via
GlobeNewswire
ZimVie Announces the Recent Launches of RegenerOss® CC Allograft Particulate and RegenerOss® Bone Graft Plug
April 13, 2023
New offerings in ZimVie’s extensive portfolio of dental bone graft solutions enhance selection for customers and bolster cadence of recent product launches
From
ZimVie Inc.
Via
GlobeNewswire
ZimVie to Report First Quarter 2023 Financial Results on May 3, 2023
April 12, 2023
From
ZimVie Inc.
Via
GlobeNewswire
ZimVie Announces Expanded Reimbursement and Exemplary Clinical Rating for Mobi-C®
April 03, 2023
Mobi-C obtains French government reimbursement and the highest quality rating from the British clinical data panel ODEP
From
ZimVie Inc.
Via
GlobeNewswire
ZimVie’s Exclusive Puros® Cancellous Particulate Allograft Dental Bone Grafting Solution Excels in Landmark Comparative Study in The International Journal of Oral & Maxillofacial Implants
March 23, 2023
Publication highlights Puros Cancellous Particulate Allograft’s collagen microstructure and greater surface area for significantly higher mesenchymal stromal cellular (hBMSC) response compared to...
From
ZimVie Inc.
Via
GlobeNewswire
ZimVie Announces Additional Positive Policy Decisions for Vertebral Body Tethering
March 15, 2023
The Tether™ device now deemed “medically necessary” for the treatment of pediatric scoliosis in additional patients covered by Highmark and BCBS North Dakota
From
ZimVie Inc.
Via
GlobeNewswire
(ZIMV) - Analyzing ZimVie's Short Interest
↗
March 03, 2023
ZimVie's (NASDAQ:ZIMV) short percent of float has fallen 84.44% since its last report. The company recently reported that it has 774 thousand shares sold short, which is 3.7% of all regular shares that...
Via
Benzinga
Why ZimVie Stock Was Plummeting on Thursday
↗
March 02, 2023
The specialty healthcare devices and tech purveyor disappointed with both fourth-quarter figures and full-year guidance.
Via
The Motley Fool
Dow Jumps Over 300 Points; Best Buy Profit Beats Views
↗
March 02, 2023
U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining more than 300 points on Thursday. The Dow traded up 0.97% to 32,978.95 while the NASDAQ rose 0.59% to 11,446.55. The S&P...
Via
Benzinga
Why Cano Health Shares Are Trading Lower By Around 23%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
↗
March 02, 2023
Gainers Exela Technologies, Inc. (NASDAQ: XELA) shares surged 45% to $0.0701 after the company announced $51 million of new funding, amendment increases existing securitization facility to $185 million...
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
↗
March 02, 2023
Via
Benzinga
< Previous
1
2
3
4
5
6
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
